PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 - 24/7 Wall St. S&P 5006,362.40 -2.11% Nikkei 22551,507.00 -2.23% Investing PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 By Michael WilliamsPublished Mar 28, 7:15AM EDT Quick Read VanEck Pharmaceutical ETF (PPH) is 17.91% concentrated in Eli Lilly (LLY), which has fallen 16% year-to- date as generic GLP-1 competition and patent expirations in emerging markets threaten ...